Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Celiac Disease and Prospective Follow-up Study

NCT04958356 is registered in ClinicalTrials.gov with University of Helsinki as lead sponsor.

NCT NCT04958356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04958356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Celiac Disease and Prospective Follow-up Study
Lead sponsor
University of Helsinki
Phase
Observational
Overall status
Active, not recruiting
Start date
November 19, 2018
Completion date
December 31, 2032
Enrollment
9,690 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease, type1diabetes